Guides

Changing GLP-1 providers means coordinating care, pharmacy arrangements and billing. Use this handover checklist to compare the next service without assuming your prescription, dose or prepaid balance will carry over.

Around half the patients Walgreens has served under the Medicare GLP-1 Bridge had never taken a GLP-1 before, its chief pharmacy officer told NPR. The Bridge hands you a $50 prescription at a drugstore counter and no care team. This is the first 90 days mapped onto the FDA labels' own titration tables, the age-relevant cautions those labels carry, and what the $50 does not cover.

Berberine picked up the nickname "nature's Ozempic" on TikTok. The two compounds act on different targets, and the meta-analysis that looked directly at body weight found no significant effect.

What the Ozempic, Wegovy, Mounjaro and Zepbound labels actually say about the fridge, the counter, a hot car, a freezer, and an airport checkpoint. Each answer is in the first sentence, because you are probably reading this in a hurry.

Every legal route to semaglutide runs through a licensed prescriber and a licensed pharmacy. This is the decision tree: how legitimate telehealth flows work, brand versus compounded, and the red flags that mark an illegal seller.

A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you are looking at, using what the STEP and SURMOUNT trials actually measured.

Clinical trials show 14.9-20.7% body weight loss with semaglutide depending on dose. Standard Wegovy (2.4mg): 14.9-17% over 68 weeks. Wegovy HD (7.2mg, FDA-approved March 2026): 20.7% over 72 weeks. Month-by-month breakdown from the STEP trials.

Price checked September 20, 2026: Foundayo is Lilly's FDA-approved non-peptide GLP-1 pill. LillyDirect self-pay is $149 at 0.8 or promotional 2.5 mg, $199 at promotional 5.5 mg, $299 at 9 mg, and $299 at 14.5 or 17.2 mg with a qualifying 45-day refill, otherwise $349. The 2.5 and 5.5 mg promotions run through December 31, 2026. No fasting is required.

FDA-approved GLP-1 receptor agonists for weight loss, 2026 guide. Eligibility: BMI 30+ (or 27+ with comorbidity). Semaglutide produces 14.9% weight loss (STEP-1), tirzepatide 20.9% (SURMOUNT-1). Cost: $25-$349/mo via telehealth. Complete 5-step prescription process with verified provider pricing. Options: Foundayo (orforglipron), oral Wegovy, Zepbound, and injectable semaglutide.

GLP-1 patches sold online don't contain semaglutide or tirzepatide, they're herbal supplements. Here's what the science says and what actually works.